06 Oct 2026, 09:00 IST
Gland pharma (GLAPH)
ICICI Securities – Retail Equity Research (ICICI Direct Research) · Buy · target 3220
The report keeps open a 14-day buy call recommended on 7 September 2026 in the 2940-3010 range with target 3220 and stop loss 2888, citing consolidation around the 20-day EMA followed by a breakout.
From momentum picks (37), written by ICICI Securities – Retail Equity Research (ICICI Direct Research) and hosted by Investment Guru India. Orivam summarised it; the view is ICICI Securities – Retail Equity Research (ICICI Direct Research)'s, not Orivam's.
Open the original PDF on Investment Guru India →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.